Skip to main content
Tags: white house | drug pricing | regeneron

White House to Announce Drug Pricing Deal With Regeneron

Thursday, 23 April 2026 01:04 PM EDT

The White House will announce ‌a drug ​pricing deal with Regeneron Pharmaceuticals on Thursday, ⁠according to a ​source familiar with the matter.

Regeneron ⁠is the sole drugmaker among 17 large pharmaceutical companies ‌that received ​letters from President Donald ‌Trump in July ‌that was left to sign such an ⁠agreement.

The company ‌did not ⁠immediately respond to ⁠Reuters' ⁠request for comment.

Shares of the company ‌were up more than 2% in morning trading. 

© 2026 Thomson/Reuters. All rights reserved.


Politics
The White House will announce ‌a drug ​pricing deal with Regeneron Pharmaceuticals on Thursday, ⁠according to a ​source familiar with the matter.
white house, drug pricing, regeneron
72
2026-04-23
Thursday, 23 April 2026 01:04 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the Newsmax App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved